Evolving Paradigms for Lipid Emulsion Use in Clinical Practice

	PROGRAM CHAIR AND MODERATOR Nancy M. Holekamp, MD Professor of Clinical Ophthalmology Washington University School of Medicine Director, Retina Services Pepose Vision Institute St Louis, Missouri
	FACULTY Jaclyn L. Kovach, MD Associate Professor of Clinical Ophthalmology Bascom Palmer Eye Institute University of Miami Health Systems Naples, Florida
	Eleonora Lad, MD, PhD Associate Professor of Ophthalmology Director of Grading, Duke Reading Center Faculty, Duke Institute for Brain Sciences Duke University School of Medicine Durham, North Carolina
	Jennifer I. Lim, MD Professor of Ophthalmology Marion H. Schenk, Esq, Chair in Ophthalmology for Research in the Aging Eye Director, Retina Service Department of Ophthalmology University of Illinois College of Medicine Chicago, Illinois

TARGET AUDIENCE

This educational activity is intended for retina specialists and other ophthalmologists caring for patients with diabetic retinopathy.

LEARNING OBJECTIVES

Upon completion of this activity, participants will be better able to:

•	Analyze the evidence supporting treatment for preventing vision-threatening outcomes in diabetic retinopathy
•	Examine clinical trial data supporting treatment of nonproliferative diabetic retinopathy to prevent diabetic retinopathy progression and diabetic macular edema
•	Design treatment plans for diabetic retinopathy that consider individual patient factors
•	Identify information that should be shared with patients with diabetic retinopathy to help them prevent vision loss

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC. The New York Eye and Ear Infirmary of Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.

In July 2013, the Accreditation Council for Continuing Medical Education (ACCME) awarded New York Eye and Ear Infirmary of Mount Sinai “Accreditation with Commendation,” for six years as a provider of continuing medical education for physicians, the highest accreditation status awarded by the ACCME.

AMA CREDIT DESIGNATION STATEMENT

The New York Eye and Ear Infirmary of Mount Sinai designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing medical education activity is jointly provided by New York Eye and Ear Infirmary of
Mount Sinai and MedEdicus LLC, in collaboration with Women in Retina, a section of ASRS.

This continuing medical education activity is supported through an unrestricted educational grant from
Regeneron Pharmaceuticals, Inc.

Distributed by

©2019 MedEdicus LLC. 184
MedEdicus LLC, 73 Redding Road, PO Box 839, Georgetown CT 06829
If you do not wish to receive email from MedEdicus in the future, please click here.